WITHDRAWN: Mouthrinses for the treatment of halitosis.

Cochrane Oral Health withdrew this review as of Issue 5, 2016.
 This review is being updated and replaced following the publication of a new expanded protocol on the effects of different interventions for the management of halitosis (Pedrazzi V, do Nascimento C, Mardegan Issa JP, Fedorowicz Z. Interventions for managing halitosis (Protocol).

Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children.

Background: Allergic rhinitis is a very common chronic illness affecting 10% to 40% of children worldwide and its prevalence among children has significantly increased over the last two decades. Prevalence and severity are related to age, with children of school age most commonly affected.

Objectives: To assess the effectiveness and adverse event profile of antihistamines (oral or topical) used as an adjunct to topical nasal steroids for intermittent and persistent allergic rhinitis in children.

Mouthrinses for the treatment of halitosis.

Background: Halitosis is an unpleasant odour emanating from the oral cavity. Mouthwashes, which are commonly used for dealing with oral malodour, can be generally divided into those that neutralize and those that mask the odour.

Objectives: To investigate the effects of mouthrinses in controlling halitosis.